Status:
COMPLETED
The 400m-walk-test for Stable Coronary Patients
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Chronic Coronary
Eligibility:
All Genders
55+ years
Phase:
NA
Brief Summary
The objective of this project is to clarify and improve the efficiency of the standardized walk-test in Cardiovascular Rehabilitation. The psycho-metric properties of the 400m walk test at a self-sele...
Eligibility Criteria
Inclusion
- Patient received enlightened information on research.
- Patient affiliated to healthcare insurance.
- Patients who agreed to participate in the study.
- Patient male or female aged 55 or more.
- Chronic coronary patient who completed his rehabilitation program.
- Patient able to understand simple orders.
- Indication of outpatient rehabilitation in coronary angioplasty + stenting, surgical coronary revascularization (coronary artery bypass), acute coronary syndrome (STEMI or NO STEMI) or stable angina suites.
Exclusion
- Patient under guardianship or tutelage
- Arrhythmia or pace maker (making criterion heart rate unusable).
- Congestive heart failure with left ventricular ejection fraction \<45% measured by trans-thoracic echocardiography according to Simpson's method or assay plasma N-terminal pro-brain natriuretic peptide (NT-pro-BNP-3) times the values used in healthy subjects by the analytical laboratory of the University Hospital of Dijon.
- Severe obstructive cardiomyopathy.
- Aortic valve.
- Thrombus intra cavitary.
- Severe pulmonary hypertension (\> 70 mm Hg).
- History of venous thromboembolism in the last 3 months.
- Heart Transplantation.
- Chronic motor impairments associated with neurological (e.g. sequelae of stroke, impaired balance and coordination) or musculoskeletal origin (e.g., osteoarthritis, osteoarthritis), because the secondary functional impairment will limit the ability to work predominantly in relation to the adaptation to stress.
- Severe medical disorder associated to a significantly alteration of the functional capacity (respiratory failure, metabolic disorders such as non-stabilized progressive renal failure) and involving the vital prognosis in the short or medium term (neoplasIC pathology progressive, systemic disease, non-stabilized).
Key Trial Info
Start Date :
November 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2016
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01904929
Start Date
November 1 2013
End Date
April 1 2016
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Dijon
Dijon, France, 21079